Insider Trading History of Duncan Jason

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Duncan Jason since 2020. This trader's CIK number is 1741553. At the time of last reporting, Duncan Jason was the Chief Legal Officer and GC of Albireo Pharma, Inc.. (stock ticker symbol ALBO). Also see all insider trading activities at Albireo Pharma, Inc..


Yearly summary of insider trading at Albireo Pharma, Inc. (ALBO) by Duncan Jason

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 ALBO 0 $0 1,166 $51,167 0 $0
2022 ALBO 0 $0 3,656 $92,659 0 $0
2021 ALBO 0 $0 19,073 $685,799 16,600 $406,183
2020 ALBO 0 $0 4,719 $199,976 3,500 $84,140


Insider trading of Albireo Pharma, Inc. (ALBO) by Duncan Jason

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-01-23 ALBO Sale 228 43.80 9,986
2023-01-19 ALBO Sale 938 43.90 41,181
2022-10-24 ALBO Sale 656 19.50 12,793
2022-07-25 ALBO Sale 313 24.02 7,519
2022-07-22 ALBO Sale 344 24.56 8,450
2022-04-25 ALBO Sale 312 33.42 10,427
2022-04-22 ALBO Sale 343 33.00 11,318
2022-01-24 ALBO Sale 1,688 24.97 42,152
2021-10-22 ALBO Sale 95 28.85 2,740
2021-10-25 ALBO Sale 217 29.21 6,338
2021-07-23 ALBO Sale 223 31.43 7,008
2021-07-22 ALBO Sale 90 34.13 3,071
2021-06-24 ALBO Option Ex 10,000 24.36 243,550
2021-06-25 ALBO Option Ex 6,300 24.67 155,421
2021-06-24 ALBO Sale 10,000 36.38 363,800
2021-06-25 ALBO Sale 6,300 36.22 228,186
2021-04-22 ALBO Sale 90 31.75 2,857
2021-04-23 ALBO Sale 222 32.32 7,175
2021-04-01 ALBO Option Ex 300 24.04 7,212
2021-04-01 ALBO Sale 300 36.16 10,847
2021-03-31 ALBO Sale 1,426 35.04 49,969
2021-01-22 ALBO Sale 110 34.62 3,808
2020-10-22 ALBO Sale 89 34.71 3,089
2020-09-08 ALBO Option Ex 3,500 24.04 84,140
2020-09-08 ALBO Sale 4,000 45.55 182,200
2020-07-22 ALBO Sale 91 25.80 2,347
2020-04-22 ALBO Sale 92 17.68 1,626
2020-01-22 ALBO Sale 447 23.97 10,714

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Duncan Jason (Chief Legal Officer and GC of Albireo Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.